Congruently, relative to healthy controls, increased frequencies of NK cells expressing LIR‐1 have been observed in patients with malignancies such as colorectal cancer, triple‐negative breast cancer (TNBC) and acute myeloid leukaemia,35, 36, 37 who often have sustained systemic inflammation. This evidence concerns the gene LILRB1 and colorectal cancer.